FORT LAUDERDALE, Fla., March 7, 2019 /PRNewswire/ -- Scientists at Life Extension announced today the development of an easy-to-take chewable supplement designed to relieve occasional minor pain and discomfort with palmitoylethanolamide (PEA) as the main ingredient in their new PEA Discomfort Relief. Numerous clinical studies have validated PEA's efficacy to help consumers find relief for their minor pains.
A whopping 25.3 million U.S. adults say they've experienced daily pain for the preceding three months, according to the 2012 National Health Interview Survey (NHIS).
"PEA is a game changer. This unique fatty acid, which is also found naturally in the body, targets an underlying step in the development of minor pain and discomfort," says Dr. Michael Smith, Life Extension Education Director.
PEA's effectiveness has been demonstrated in multiple clinical studies. In fact, 600 mg of PEA given every day for three weeks significantly improved relative comfort and quality of life scores during a randomized, placebo-controlled trial following 636 patients. To learn more about PEA visit lifeextension.com.
Life Extension is committed to innovating science-based, clinically studied supplements, while also conveying medical news, updates and breakthroughs to their customers. Enhancing and expanding human life is the driving force that inspires the science, methodology, research and formulation of every product created by the professionals at Life Extension. For more than 35 years, this Fort Lauderdale, Florida-based company has pioneered the science prompting many, now common, life enhancing ideologies like those around integrative health therapies contributing more than $175 million in health and medical research.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |
SOURCE Life Extension
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article